Interventional Revascularization of Coronary Artery Lesions in Diabetic Patients; In-hospital and One Year Follow up

Mohammad Javad Zibaeenezhad1, Amir Aslani1, Alireza Moniri1

  • 1Cardiovascular Research Center, Shiraz University of Medical Science, Shiraz, IR Iran.

Insights

Drug-eluting stents show comparable safety and efficacy for single or two-vessel coronary artery disease in diabetic patients. This intervention can be a safe alternative to coronary artery bypass grafting.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Diabetology

Background:

  • Diabetes mellitus presents significant risks for micro- and macrovascular complications.
  • Limited research exists on the efficacy of coronary revascularization modalities in diabetic populations.
  • Diabetic patients face heightened risks from cardiovascular diseases.

Purpose of the Study:

  • To evaluate in-hospital complications and one-year clinical outcomes after percutaneous coronary intervention (PCI) in diabetic patients.
  • To compare the efficacy of single-vessel versus two-vessel stenting in diabetic individuals undergoing PCI.
  • To assess the safety and effectiveness of drug-eluting stents (DES) in diabetic patients with coronary artery disease.

Main Methods:

  • A study of 200 consecutive patients undergoing PCI between 2007 and 2009.
  • In-hospital complications and one-year clinical outcomes were meticulously recorded and analyzed.
  • Comparison of outcomes between diabetic and non-diabetic patients, and between single and two-vessel stenting.

Main Results:

  • No statistically significant difference in major adverse cardiovascular events was observed between diabetic and non-diabetic patients.
  • Outcomes for single-vessel stenting were comparable to two-vessel stenting in diabetic patients.
  • Drug-eluting stents demonstrated similar long-term and in-hospital outcomes for both one and two-vessel stenting in diabetic individuals.

Conclusions:

  • Percutaneous coronary intervention with drug-eluting stents is technically satisfactory and clinically safe for diabetic patients with single or two-vessel disease.
  • Drug-eluting stent implantation in diabetic patients can serve as a viable alternative to coronary artery bypass grafting.
  • PCI with DES offers a safe and effective revascularization strategy for diabetic patients with coronary artery lesions.
Abstract

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
444
Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
55
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
655
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
764
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
753
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
741